The $24 million mediated settlement stems from a string of patient deaths that nearly derailed Seattle’s star biotech startup two years ago.
The rest is here:
Juno Therapeutics and investors reach settlement related to fatal drug trial
Juno Therapeutics and investors reach settlement related to fatal drug trial
Over the years, through our many assignments, the Principals of Revitalization Partners frequently said to ourselves: “One day, we should write a book about our work and how we can help companies through our experiences.” This is that book and we hope that you find words of value to you and your business.